-transparent.png){kind=logo}
The effect of the adenosine diphosphoribosyltransferase inhibitors, the substituted benzamides, on the cytotoxicity of 6-thioguanine (6TG) was investigated. Nontoxic concentrations of benzamides potentiated the cytotoxicity of 6TG with a dose enhancement factor of 2, producing a 6-fold increase in cell killing at 10% survival. 6TG treatment did not deplete cellular NAD levels, and in the presence of 3-aminobenzamide, there was no increase in the number of 6TG-induced DNA strand breaks. To obtain potentiation of cytotoxicity, 3-aminobenzamide had to be present in late G1-S phase during the cell cycle in which 6TG is incorporated into the DNA. These data indicate that the substituted benzamides potentiate the cytotoxicity of 6TG by a mechanism independent of an inhibition of DNA repair.
K Moses, and
A L Harris, and
B W Durkacz
January 1981,
Cancer biochemistry biophysics,
K Moses, and
A L Harris, and
B W Durkacz
February 1986,
Analytical biochemistry,
K Moses, and
A L Harris, and
B W Durkacz
April 2013,
Biochemistry,
K Moses, and
A L Harris, and
B W Durkacz
September 1984,
International journal of radiation oncology, biology, physics,
K Moses, and
A L Harris, and
B W Durkacz
November 1999,
The Journal of biological chemistry,
K Moses, and
A L Harris, and
B W Durkacz
November 1982,
Biochemical and biophysical research communications,
K Moses, and
A L Harris, and
B W Durkacz
August 1987,
Proceedings of the National Academy of Sciences of the United States of America,
K Moses, and
A L Harris, and
B W Durkacz
July 2016,
Journal of biomolecular screening,
K Moses, and
A L Harris, and
B W Durkacz
December 2000,
Sheng li xue bao : [Acta physiologica Sinica],
K Moses, and
A L Harris, and
B W Durkacz
February 1982,
The Journal of biological chemistry,
